DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Scott Weiner will speak about Pappas Ventures' perspective on the Medtech market at the IN3 West: Investment in Innovation Conference in Las Vegas, NV.
News | 02. 22. 2011
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.